Difelikefalin for severe chronic kidney disease-associated pruritus in a patient in dialysis
Ugeskrift for Læger · 2025
DOI: 10.61409/v09240621 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ugeskrift for Læger, 2025. Verfasst von Gustav Østerlund Larsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nyresygdomme, Aarhus Universitetshospital. Hauptthemen laut MEDLINE: Pruritus, Renal Insufficiency, Chronic, Antipruritics. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
In this case report, a 72-year-old male haemodialysis patient with severe chronic kidney disease-associated pruritus (CKD-aP) was given difelikefalin (DFK) 50 μg × 3/week after unsuccessful standard therapy including fatty cream, steroids, antihistamines, gabapentinoids, and UV-light. CKD-aP was verified by a dermatologist before DFK was given. After three weeks, CKD-aP had improved markedly. The worst itch numeric rate scale (range: 0-10) dropped to 0 from 7-8 prior to DFK. DFK caused drowsiness which disappeared when the treatment was paused. DFK dose was then reduced to 25 μg × 3/week which was well tolerated. The skin healed, except for scars caused by scratching.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nyresygdomme, Aarhus Universitetshospital.
- Institut for Klinisk Medicin, Aarhus Universitet.
Zitieren
APA
Larsen, G. Ø., Kjærgaard, K. D., & Peters, C. D. (2025). Difelikefalin for severe chronic kidney disease-associated pruritus in a patient in dialysis. Ugeskrift for Læger. https://doi.org/10.61409/v09240621
Vancouver
Larsen GØ, Kjærgaard KD, Peters CD. Difelikefalin for severe chronic kidney disease-associated pruritus in a patient in dialysis. Ugeskrift for Læger. 2025. doi:10.61409/v09240621
BibTeX
@article{Larsen2025,
author = {Larsen, Gustav Østerlund and Kjærgaard, Krista Dybtved and Peters, Christian Daugaard},
title = {Difelikefalin for severe chronic kidney disease-associated pruritus in a patient in dialysis},
journal = {Ugeskrift for Læger},
year = {2025},
doi = {10.61409/v09240621}
}
EUVIMED